Financial Street Forum: Patient capital fuels China humanoid robots

China's robotics sector is demonstrating remarkable technological advances, with companies like Galbot achieving breakthroughs in embodied AI and large-scale commercial deployment. Behind this innovation lies a crucial enabler: the nation's strategic "patient capital" that supports long-term technological development. This approach, aligned with China's AI+ initiative and 15th Five-Year Plan priorities, provides comprehensive, life-cycle financial support for tech transformation projects. Robin Xing, Morgan Stanley's chief China economist, noted at the Financial Street Forum that China has established itself as a leading AI power with a comprehensive ecosystem – from hardware to infrastructure. This solid foundation, combined with sustained investment in core technologies, is creating compelling opportunities for global investors looking to participate in China's tech self-reliance journey.